 |
Deposito minimo $50 Promozione esclusiva |
Il nostro punteggio |
0% commissione |
Are you looking to buy NuVasive stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:NUVA! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about NuVasive stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company’s principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company’s biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Volume medio
859,900 shs
TAPPA DEL MERCATO
$3.00 billion
Borsa valori
NASDAQ
Compri queste azioni!
|
NOME
|
TICKER
|
INDUSTRIA
|
SETTORE
|
VOLUME
|
COMPRI ORA QUESTE AZIONI
|
|---|---|---|---|---|---|
|
NASDAQ:NUVA
|
Strumenti chirurgici e medici
|
Medico
|
11,309 shs
|
Below is a quick guide on how to buy NASDAQ:NUVA stocks safe, fast and around the world in less than five minutes.
Passo 1: Aprire un conto con eToro – eToro is the best broker to buy NuVasive shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: caricare il suo ID - Come da regolamento KYC eToro le chiederà di caricare una copia del suo passaporto o della sua patente di guida.
Passo 3: Deposito di fondi - Depositi del denaro nel suo conto eToro appena creato. Può scegliere tra bonifico bancario, e-wallet o carta di debito/credito o Paypal.
Passo 4: Buy NuVasive – Search for “”NASDAQ:NUVA”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought NuVasive stocks with 0% commission!.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
17 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for NuVasive in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” NuVasive stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUVA, but not buy additional shares or sell existing shares.
Wall Street analysts have given NuVasive a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but NuVasive wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
2 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
3 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:NUVA stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy NuVasive stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy NuVasive stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Poiché eToro è una piattaforma regolamentata, dovrà completare il processo KYC, questa è una pratica standard e richiede solo un paio di minuti. Dovrà fornire un documento d'identità con foto (passaporto, patente) e una prova di indirizzo (bolletta, estratto conto bancario).
Una volta iscritto e verificato il suo conto, dovrà depositare dei fondi. eToro accetta carte di credito/debito, trasferimenti bancari e anche portafogli elettronici. Quindi qualunque sia la sua preferenza ci sarà qualcosa per lei.
Now that you’ve funded your eToro account, just type “NASDAQ:NUVA stocks" nella barra di ricerca nella parte superiore dello schermo e prema "trade".
All that’s left is to buy some NASDAQ:NUVA stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:NUVA is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy NuVasive stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
NuVasive is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for NuVasive.
NuVasive, Inc. (NASDAQ:NUVA) posted its quarterly earnings data on Thursday, October, 29th. The medical device company reported $0.55 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.31. The medical device company earned $295.30 million during the quarter, compared to analysts’ expectations of $257.70 million. NuVasive had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 8.00%. NuVasive’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $0.59 EPS.
View NuVasive’s earnings history.
NuVasive’s stock was trading at $49.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NUVA stock has increased by 18.6% and is now trading at $58.61.
17 equities research analysts have issued 12-month price targets for NuVasive’s shares. Their forecasts range from $48.00 to $85.00. On average, they anticipate NuVasive’s share price to reach $62.00 in the next twelve months. This suggests a possible upside of 5.8% from the stock’s current price.
View analysts’ price targets for NuVasive or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:NUVA stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Oltre 95% dei fondi dei clienti sono tenuti offline, in depositi freddi, il che è fondamentale per qualsiasi broker che gestisce i suoi beni. Indipendentemente da quanto sia sicura una piattaforma, raccomandiamo di usare 2FA per aggiungere un ulteriore livello di sicurezza al suo conto.
eToro offre agli utenti una serie di caratteristiche per iniziare ad investire il più rapidamente possibile. Hanno una caratteristica relativamente unica chiamata copy trading, che le permette di guadagnare un reddito passivo facendo da specchio a trader esperti, questo le permette di iniziare a guadagnare rapidamente e le dà una migliore comprensione delle strategie usate dai professionisti. Inoltre, eToro permette agli utenti di investire in portafogli gestiti, un portafoglio gestito è una varietà di asset simili raggruppati insieme, che le permette di diversificare il suo conto, riducendo qualsiasi rischio potenziale. Per chi ha esperienza di trading precedente, può investire in mercati al di fuori delle azioni, dato che eToro permette agli utenti di commerciare ETF, materie prime, cripto e indici. Se già investe al di fuori dello spazio del mercato azionario questo può essere molto utile, perché le permette di gestire tutti i suoi investimenti in un solo posto.
NuVasive’s management team includes the following people:
Mr. J. Christopher Barry, CEO & Director (Age 48, Pay $2.43M)
Mr. Nathaniel B. Sisitsky Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 47, Pay $686.56k)
Mr. Matthew K. Harbaugh, Exec. VP & CFO (Age 51)
Mr. Dale A. Wolf, Sr. VP of Global Operations (Age 41)
Mr. Johnson Lai, Chief Information Officer
Mr. Sean Freeman, Sr. VP of Strategy & Corp. Devel.
Mr. Lucas Vitale, Sr. VP & Chief HR Officer (Age 44)
Mr. Frank Middeke, Managing Director of DACH
Ms. Lisa Pecora, VP & Head of Global Commercial Fin.
Mr. Brent J. Boucher, Exec. VP of Global Commercial (Age 54)
59 employees have rated NuVasive CEO Chris Barry on Glassdoor.com. Chris Barry has an approval rating of 88% among NuVasive’s employees.
I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva. Il 68% dei conti degli investitori al dettaglio perdono denaro quando scambiano CFD con questo fornitore. Deve considerare se capisce come funzionano i CFD e se può permettersi di correre l'alto rischio di perdere i suoi soldi.
Some companies that are related to NuVasive include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and Varian Medical Systems (VAR).
View all of NUVA’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other NuVasive investors own include BioMarin Pharmaceutical (BMRN), Incyte (INCY), Puma Biotechnology (PBYI), Intel (INTC), Alibaba Group (BABA), (MDVN) (MDVN), Micron Technology (MU), Bank of America (BAC), Gilead Sciences (GILD) and Applied Materials (AMAT).
NuVasive trades on the NASDAQ under the ticker symbol “NUVA.”
NuVasive’s stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (2.09%), Fisher Asset Management LLC (1.84%), Scout Investments Inc. (0.98%), Fort Washington Investment Advisors Inc. OH (0.42%), Gamco Investors INC. ET AL (0.33%) and State of Wisconsin Investment Board (0.25%). Company insiders that own NuVasive stock include Gregory T Lucier, Matthew Link and Paul Mcclintock.
View institutional ownership trends for NuVasive.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
NUVA stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Ziegler Capital Management LLC, SG Americas Securities LLC, State of Wisconsin Investment Board, Texas Permanent School Fund, Pacer Advisors Inc., New York State Teachers Retirement System, and California Public Employees Retirement System.
View insider buying and selling activity for NuVasive or view top insider-selling stocks.
NUVA stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc., Fort Washington Investment Advisors Inc. OH, Tower View Investment Management & Research LLC, Zurcher Kantonalbank Zurich Cantonalbank , Y Intercept Hong Kong Ltd, Gamco Investors INC. ET AL, Acorn Financial Advisory Services Inc. ADV, and IFP Advisors Inc.
View insider buying and selling activity for NuVasive or or view top insider-buying stocks.
Shares of NUVA can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Recensione di Interactive Brokers, Recensione di eToro, Recensione di DEGiro, Recensione di AvaTrade, Recensione di IG Markets, Rassegna dei mercati IC, Recensione di CMC Markets, Recensione di Admiral Markets e molti altri. Legga una delle recensioni per scoprire tutto sul broker e inizi a comprare azioni ora.
One share of NUVA stock can currently be purchased for approximately $58.61.
NuVasive has a market capitalization of $3.01 billion and generates $1.17 billion in revenue each year. The medical device company earns $65.23 million in net income (profit) each year or $2.47 on an earnings per share basis.
NuVasive employs 2,800 workers across the globe.
A Reportlab.org vogliamo assicurarci che lei abbia tutte le informazioni più rilevanti su acquisto di azioni. Le portiamo le migliori guide sul mercato azionario con recensioni personali, informazioni di base, recensioni di piattaforme, how to's e altro. Vuole ottenere altre informazioni? Allora dia un'occhiata al Azioni OTC, Azioni del NASDAQ, Azioni del NYSE, Azioni LON, Scorte FRA, Azioni ETR, Scorte dell'EPA, Azioni del TSX o Azioni Amex. Cercando informazioni più dettagliate come 5g stock, azioni biotecnologiche, azioni d'oro e altre informazioni dal nostro reportlab.
How can you buy NuVasive stock on the internet?
You can easily buy NuVasive stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Un'altra opzione è usare un broker regolamentato come Mercati IC o Brokers interattivi. You can an account with these brokers and start buying or trading NASDAQ:NUVA stocks in a safe and complete environment to trade in.
Where to buy NuVasive stock?
You will first want to find a licensed broker that supports NASDAQ:NUVA stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:NUVA stocks in a safe and complete environment.
Is NASDAQ:NUVA stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:NUVA stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is NuVasive stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:NUVA is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in NuVasive stock.
How do you trade NuVasive stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for NuVasive stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:NUVA stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell NuVasive stock?
To sell your NASDAQ:NUVA stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best NuVasive stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:NUVA stock.
Stephen conosce molto bene i prodotti finanziari e in particolare ha una grande passione per i mercati azionari e i suoi partecipanti. Speriamo che le informazioni fornite le siano utili. C'è qualcosa di poco chiaro? Lasci le sue domande o commenti in fondo alla pagina.
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ |
Notiziario
Notizie recenti
| |
Il nostro punteggio |
0% commissione |
Dati in tempo reale su azioni e criptovalute
Notifiche, Consigli e Notizie
Le migliori guide su azioni e criptovalute
Recensioni su broker e scambi online
Reportlab Finanza è un sito web puramente informativo e non implica in nessun caso consigli di investimento. Tutti gli investimenti comportano rischi e lei può perdere tutti i suoi investimenti. Non investa denaro che non può permettersi di perdere.
Reportlab Finanza
38 Holburn Lane
Heckfield Green
IP21 0UB
Regno Unito
Copyright © 2022 Reportlab.Finance | Tutti i diritti riservati.
